U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039929) titled 'Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants' on June 18.

Brief Summary: This study will be conducted to assess the safety, tolerability, and pharmacokinetics of INCB000631 when administered orally to healthy adult participants.

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: INCB000631

Oral; Tablet

DRUG: Placebo

Oral; Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Incyte Corporation

Disclaimer: Curated by HT Syndication....